InMode INMD
NASDAQ INMD
$14.79 -0.02 (-0.14%)
As of: Sep 9, 2026 · 3:59 PM EDT

InMode (INMD) EBT Margin Growth (3y) (2021 - 2026)

Analysis

InMode (INMD) EBT Margin Growth (3y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -429.00
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 803.00
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 260.00
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 574.00
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 764.00
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 835.00
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -1,045.00
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 598.00
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 423.00
10 InMode 944.68 Mn 462.56 Mn 71.52 Mn -2,456.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,456.00
Mar 31, 2026 -2,425.00
Dec 31, 2025 -1,768.00
Sep 30, 2025 -1,699.00
Jun 30, 2025 -1,016.00
Mar 31, 2025 -1,232.00
Dec 31, 2024 -1,618.00
Sep 30, 2024 -306.00
Jun 30, 2024 -1,682.00
Mar 31, 2024 -844.00
Dec 31, 2023 -131.00
Sep 30, 2023 138.00
Jun 30, 2023 1,675.00
Mar 31, 2023 2,535.00
Dec 31, 2022 709.00
Sep 30, 2022 335.00
Jun 30, 2022 100.00
Mar 31, 2022 736.00
Dec 31, 2021 4,623.00
Sep 30, 2021 1,308.00